RxDoctor Payments Data

Charles Moreland

Child & Adolescent Psychiatry · Houston, TXNPI 1316027725

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.1% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations.

$2,519in general payments, 2019–2025

Across 127 payments — averaging $19.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ironshore Pharmaceuticals Inc.$495
  • Corium, LLC$409
  • Supernus Pharmaceuticals, Inc.$310
  • Tris Pharma Inc$257
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$206
  • Takeda Pharmaceuticals U.S.A., Inc.$200
  • plus $644 from 11 others

What the payments were for

  • Food & beverage$2,47098%
  • Education$492%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,519 in reported general payments places this provider in the 85th percentile of 301 child & adolescent psychiatry providers in Texas.

See all child & adolescent psychiatry providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Vilazodone Hcl24$696
Fluvoxamine Maleate11$107

Paid to pharmacies, not to this prescriber.

Other child & adolescent psychiatry in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →